HealthEquity(HQY) - 2026 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Revenue grew 7% year-over-year to $334.6 million in Q4 fiscal 2026, with net income increasing 89% to $49.7 million [21][7] - Non-GAAP net income rose 33% to $81.8 million, and non-GAAP net income per diluted share grew 38% to $0.95 [23][7] - Adjusted EBITDA increased 23% to $132.9 million, with an adjusted EBITDA margin expansion of over 500 basis points to 40% [23][6] Business Line Data and Key Metrics Changes - Service revenue grew 2% year-over-year to $127.1 million, while custodial revenue increased 12% to $161.4 million [21] - Interchange revenue grew 6% to $46.1 million, outpacing total account growth of 4% [21] - Total HSA assets increased 14% to over $36 billion, with a record addition of 550,000 HSAs in Q4 [8][6] Market Data and Key Metrics Changes - The company added over 1 million new HSAs in a year when the U.S. economy added just 181,000 jobs, indicating strong demand for HSAs [9][10] - The policy environment for HSAs is the most favorable it has been in two decades, with significant legislative changes expanding HSA eligibility [17][18] Company Strategy and Development Direction - The company is focused on a flywheel strategy that enhances member engagement through saving, spending, and investing for healthcare [7][10] - Expansion into retail healthcare channels and direct HSA enrollment platforms is a key strategic initiative [10][11] - The company is investing in AI to enhance member experience, operational efficiency, and personalization at scale [14][13] Management's Comments on Operating Environment and Future Outlook - Management highlighted that healthcare affordability pressures are driving the adoption of consumer-directed healthcare, which is expected to continue [11][62] - The company anticipates continued revenue growth and margin expansion in fiscal 2027, raising guidance based on strong execution and visibility [29][30] Other Important Information - The company returned over $300 million to shareholders through share repurchase programs in fiscal 2026, reducing diluted shares outstanding by approximately 3% [7][24] - The company has approximately $178 million remaining on its share purchase authorization [24] Q&A Session Summary Question: Comments on gross margin expansion and future potential - Management expressed pride in gross margin expansion driven by reduced fraud costs and operational efficiencies, with a focus on AI to enhance service delivery [32][36] Question: Engagement with early users of Marketplace offerings - Early engagement metrics are positive, with strong retention rates among members participating in initial Marketplace programs [38][41] Question: Conversion from ACA cohort and market expansion - Management noted that the ACA expansion represents a 10% market increase, with early signs of account growth starting in January [46][47] Question: Plans for reinvestment in the business - The capital allocation strategy remains focused on organic growth, share repurchases, and debt reduction, with no significant changes anticipated [51][52] Question: Trends in member spending on Marketplace offerings - Early trends indicate positive engagement with Marketplace offerings, which are expected to contribute to revenue growth over time [56][58] Question: Impact of macroeconomic trends on guidance - Management acknowledged macroeconomic challenges but emphasized that healthcare affordability is driving HSA adoption, which supports growth [60][62]